Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,524 papers from all fields of science
Search
Sign In
Create Free Account
creatol
Known as:
2-amino-5-hydroxy-1-methylimidazol-4(5H)-one
, 5-hydroxycreatinine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Creatinine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Serum accumulation of a creatinine oxidative metabolite (NZ-419: 5-hydroxy-1- methylhydatoin) as an intrinsic antioxidant in diabetic patients with or without chronic kidney disease.
G. Hasegawa
,
K. Nakano
,
K. Ienaga
Clinical Nephrology
2011
Corpus ID: 25570675
AIMS In mammals, creatinine (Cr) is catabolized by a dual oxidative pathway via 5-hydroxy-1-methylhydantoin or 5…
Expand
2007
2007
Urinary Excretion of Creatol, an In Vivo Biomarker of Hydroxyl Radical, in Patients with Chronic Renal Failure
K. Ienaga
,
Ko Nakamura
,
+8 authors
H. Koide
Renal Failure
2007
Corpus ID: 21334924
Creatol (CTL) is a hydroxyl radical adduct of creatinine (Cr). The serum methylguanidine (MG) level and the MG/Cr molar ratio are…
Expand
2000
2000
Creatol, an oxidative product of creatinine in hemodialysis patients
C. Tomida
,
K. Aoyagi
,
+4 authors
A. Koyama
Free radical research
2000
Corpus ID: 44660076
Creatol (CTL) is a product resulting from the reaction of creatinine (Cr) with the hydroxyl radical and is identified as a…
Expand
1998
1998
Synthesis of creatol, a hydroxyl radical adduct of creatinine and its increase by puromycin aminonucleoside in isolated rat hepatocytes.
K. Aoyagi
,
K. Akiyama
,
+6 authors
M. Narita
Free radical research
1998
Corpus ID: 38777682
Creatol is a hydroxyl radical adduct of creatinine and the precursor of methylguanidine (MG), a uremic toxin. We investigate the…
Expand
1997
1997
Changes in serum levels of creatol and methylguanidine in renal injury induced by lipid peroxide produced by vitamin E deficiency and GSH depletion in rats.
H. Ozasa
,
T. Watanabe
,
K. Nakamura
,
Y. Fukunaga
,
K. Ienaga
,
K. Hagiwara
Nephron
1997
Corpus ID: 46823683
A novel creatinine metabolite, creatol (5-hydroxycreatinine), is a key precursor in the synthesis of the uremic toxin…
Expand
1996
1996
Diabetic renal failure and serum accumulation of the creatinine oxidative metabolites creatol and methylguanidine.
K. Nakamura
,
K. Ienaga
,
+7 authors
T. Kanatsuna
Nephron
1996
Corpus ID: 25438019
Diabetic patients (n = 23) with chronic renal failure (CRF) accumulate the creatinine (Cr) oxidative metabolites creatol (CTL…
Expand
1994
1994
Creatol, a creatinine metabolite, as a useful determinant of renal function.
K. Nakamura
,
K. Ienaga
,
+7 authors
T. Kanatsuna
Nephron
1994
Corpus ID: 46768590
Analysis of creatol (CTL, 5-hydroxycreatinine), an oxidative creatinine (Cr) metabolite, in serum and urine of human subjects has…
Expand
1993
1993
Comparison of renal effects of creatinine, creatol and methylguanidine in rats with adenine-induced chronic renal failure.
T. Yokozawa
,
H. Oura
,
K. Ienaga
,
K. Nakamura
Nephron
1993
Corpus ID: 3324832
Creatinine (Cr), creatol and methylguanidine (MG), which accumulate in the body with the progress of renal failure after adenine…
Expand
1993
1993
Purification of methylguanidine synthase from the rat kidney.
T. Yokozawa
,
N. Fujitsuka
,
+5 authors
M. Hattori
Nephron
1993
Corpus ID: 3209024
Methylguanidine (MG)-synthesizing enzyme was purified from rat kidney lysosomes and peroxisomes. The enzyme was a flavoprotein…
Expand
1990
1990
Creatol (5-hydroxycreatinine), a new toxin candidate in uremic patients
K. Nakamura
,
K. Ienaga
Experientia
1990
Corpus ID: 43620939
Both 5-hydroxy-1-methylhydantoin (3) and the hitherto unrecognized 5-hydroxycreatinine (2-amino-5-hydroxy-1-methyl-imidazol-4(5H…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE